Navigation Menu

Skip to Navigation menu Skip to top of page

22 September 2008

Pharma companies rejoice at GSK judgment

Stephen Mulrenan, London

The pharmaceutical industry is celebrating a European Court of Justice (ECJ) decision that states that even dominant companies can take reasonable and proportional steps to protect their own commercial interests against parallel trade

But the verdict has left more questions than answers for many practitioners.




The rest of this article is available to subscribers to Managing IP only.

Subscribe today to this product for full access to this article. Alternatively, take a 48-hour free trial giving you access to the current content.

If you are already a subscriber please log in (see top right column) to access the rest of this article.